Re: USTR Press Release on Argentina

I think that it might be useful at this point to try and move back to the
Internet issue. I have been sitting here for the past five minutes or so,
attempting to come up with some concise correlation between the
conversations involving intellectual property in pharmeceutical research
and the internet. There are some issues presented, namely international
threats of plagarism and the validity of use of secondary research. But
what are the growing policies on this issue for the Internet? Where is the
tie that links this thread to our class?